At Endomag, we believe everyone deserves a better standard of cancer care. Many of the world’s leading physicians and hospitals use our magnetic technologies to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is.
One of these technologies is Magtrace® lymphatic tracer, the world’s first, long-lasting, non-radioactive dual tracer for lymphatic mapping. With its longer injection window, it is now allowing surgeons to avoid unnecessary lymph node surgery in some cases, reducing the risk of lymphedema, thanks to the revolutionary ‘delayed’ sentinel lymph node biopsy procedure.
Find out more at www.endomag.com